RxDoctor Payments Data

Matthew Alef

Vascular Surgery · Lebanon, NHNPI 1639371610

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Cook Incorporated at 55.9% of the total. Among vascular surgery clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,824in general payments, 2019–2025

Across 61 payments — averaging $406.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$14K
  • Penumbra, Inc.$4K
  • Cook Medical LLC$3K
  • GE HealthCare$3K
  • Bolton Medical Inc$259
  • Shape Memory Medical Inc.$187
  • plus $683 from 6 others
$9,917in research payments, 2019–2025

Across 25 payments — averaging $396.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endologix LLC$10K

What the payments were for

  • Consulting fees$2,60010%
  • Speaking & faculty fees$12,94052%
  • Travel & lodging$5,55222%
  • Food & beverage$3,73215%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,824 in reported general payments places this provider in the 90th percentile of 43 vascular surgery providers in New Hampshire.

See all vascular surgery providers in New Hampshire

Medicare billing

Part B allowed, 2024
$110,577
Medicare patients
494
Services billed
819

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$11,774
ClopidogrelClopidogrel Bisulfate45$415
Atorvastatin Calcium11$84

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Lebanon

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →